Loneliness and social isolation have been significant problems for the general population during the COVID-19 pandemic, but for cancer patients these issues were particularly acute, likely due to isolation and social distancing, according to a new UCSF study.
A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease.
This study builds on decades of work showing that the protein IL-24 attacks cancer broadly, and is the first to deliver the protein using T cells. This approach is in contrast to CAR-T cells, which are built to recognize proteins on the surface of cancer cells and haven't been successful against solid tumors. Mice with prostate cancer experienced shrinkage of the original tumor as well as distant metastases following treatment with IL-24 T cells.
A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of "low value" by the U.S. Preventive Services Task Force -- at a cost of $478 million per year.
During the first wave of the corona pandemic, 36 per cent fewer men were diagnosed with prostate cancer in Sweden than in previous years. On the other hand, the number of patients receiving curative treatment for prostate cancer was unaffected. This is shown by a new register study led by Uppsala University researchers, whose results are published in the Scandinavian Journal of Urology.
What The Study Did: Using insurance claims data, the change in screening rates for breast, colorectal and prostate cancers during the COVID-19 pandemic were estimated as well as the overall decline in cancer screening last year among the U.S. population.
UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein that is crucial for the function of testosterone - may destroy cancer cells. Focusing on this protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer in men.
Researchers from the University of Copenhagen have developed a new method that makes it possible to control human hormones and metabolism. One of the study's perspectives suggests that the method could be used to develop more effective medicines to treat cancer and a range of metabolic disorders in the future.
Researchers have developed a new prostate cancer urine test which shows how aggressive the disease is and could reduce invasive biopsies. A new study shows how an experimental new test called 'ExoGrail' has the potential to revolutionise how patients with suspected prostate cancer are risk-assessed prior to an invasive biopsy. The research team say their new test could reduce the number of unnecessary prostate cancer biopsies by 35 per cent.
Hongbo Pang from the U of M College of Pharmacy found a better drug delivery system to treat prostate cancer and bone growth.